Development of a universal marker of circulating tumour cells for detection, monitoring and therapeutic orientation in oncology Sirius NeoSight is developing technology to measure membrane fluidity which is a high-performance, universal methodology for the discrimination and purification of Circulating Tumour Cells (CTCs) present in the blood stream. The ambition of Sirius technology is to revolutionise […]